PRICING & INQUIRIES

For pricing and inquiries, send an email to sales@omicsoft.com.

5001 Weston Parkway, Suite 201
Cary, NC 27513
US

888-259-6642

Overview

Omicsoft is the leading provider of Next Generation Sequencing, Cancer Genomics, Immunology, and Bioinformatics solutions for Next Generation Sequencing Data and Gene Expression Analysis.

OncoLand

Incorporating user data side-by-side with large-scale public genomics datasets like TCGA

OncoLand

CANCER Genomics: IncorporatING Large Scale Public and Private Cancer DataSETS

While many large-scale cancer genomic datasets are available online for free (i.e from the TCGA Data PortalICGC portalGTEx portal, etc.), the data is not in an easily accessible or standard format.  OncoLand is an Oncology database and visualization software that helps users explore these cancer genomics datasets (either individually or pan-cancer analysis)  using its "Land" technology, allowing researches to more readily power their research.  

Download Brochure

 


Comprehensive:   Sample-centric view of genomics data and clinical data from multiple platforms

Controlled:             Standardized pipeline to process data and controlled vocabulary for clinical data

Integrated:             Integration with internal private datasets and integrate across public datasets (i.e GTEx vs TCGA)

Powerful:               Extended analytical capacity powered by Array Studio, Omicsoft’s flagship product and built-in Genome Browser

Secured:                 Trusted by increasing number of users from major pharma and biotech companies


Example Queries

  • Correlate mutation status to expression

  • List top gene fusions in disease/study

  • Detect exact fusion breakpoints for gene fusions

  • Create sample groupings on-the-fly and correlate to copy number, expression, and more.

  • Expression pattern of gene of interest (RNA-Seq or chip-based)

  • Mutation patterns or distributions (RNA or DNA level)

  • Integrate Copy Number and Expression data

  • Co-mutation frequencies

  • Compare normal tissue distribution to tumor or cell line distribution

shutterstock_145412332-2.jpg
shutterstock_136261112.jpg

Public Studies (TCGA and More)

  • Thousands of samples across large-scale cancer genomics Oncology clinical and cell line studies.
  • Compound and siRNA/shRNA can be used for correlation analysis and visualizations.
  • Clinical data allows organization of data by tumor type, histology, survival information, or disease specific end points (i.e Gleason Grade or triple-negative status).
  • Omicsoft's pipeline includes re-processing of all available RNA-Seq data, including calls for alternative splicing, gene fusions, and mutations.

Private Studies (Customer Datasets)

  • Integrate your organization's data into OncoLand.
  • Create your own "Land" and provide users the same searches, analytics, and visualizations available with the public data.
  • What does this mean in practice?  Many companies have screening data on thousands of compounds.  Use the information found in the patient data to find trends that match up with sensitivity/resistance information of company compounds.
  • Use compound sensitivity information to scan for significant mutations, expression correlation, copy number correlation, and more.

DATA SOURCES

Oncology Database: Data Types

  • RNA-Seq: EM normalized counts, normalized RPKM, Mutations, Fusions, Exon-level counts, and exon junctions
  • DNA-Seq: Germline Mutations and Somatic Mutations
  • Expression: Log2 expression, Present/Absent calls, Cross-platform percentiles
  • Copy Number: Segment-level, Log2 Ratios
  • Protein: RPPA
  • Methylation
  • Measurements: ic50 values, Sensitive/Resistant status, siRNA/shRNA, AUC, more...
shutterstock_167700644.jpg